✦ LIBER ✦

Pharmacodynamic characteristics of lixisenatide once daily versus liraglutide once daily in patients with type 2 diabetes insufficiently controlled on metformin

✍ Scribed by Kapitza, C.; Forst, T.; Coester, H.-V.; Poitiers, F.; Ruus, P.; Hincelin-Méry, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Once-daily prandial lixisenatide versus

✍ Raccah, Denis; Lin, Jay; Wang, Edward; Germé, Maeva; Perfetti, Riccardo; Bonadon 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 340 KB

Exenatide once weekly versus liraglutide

✍ Buse, John B; Nauck, Michael; Forst, Thomas; Sheu, Wayne H-H; Shenouda, Sylvia K 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 389 KB

Once-weekly dulaglutide versus once-dail

✍ Dungan, Kathleen M; Povedano, Santiago Tofé; Forst, Thomas; González, José G Gon 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 535 KB

Efficacy and safety of glimepiride/metfo

✍ Hwang, Y.-C.; Kang, M.; Ahn, C. W.; Park, J. S.; Baik, S. H.; Chung, D. J.; Jang 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB

Dose-dependent effects of the once-daily

✍ R. E. Ratner; J. Rosenstock; G. Boka; on behalf of the DRI6012 Study Investigato 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

Glycemic control in patients with type 2

✍ Ken Fujioka; Miranda Pans; Steven Joyal 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 860 KB